Mar 2, 2021 Cellectar Reports Financial Results for Year Ended December 31, 2020 and Provides a Corporate Update Learn More
Jan 27, 2021 Cellectar Receives Orphan Drug Designation from the European Commission for CLR 131 in Waldenstrom’s Macroglobulinemia Learn More
Jan 12, 2021 Cellectar Initiates Pivotal Trial of CLR 131 in Waldenstrom’s Macroglobulinemia Learn More